Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 8
Submit an article Journal homepage
484
Views
50
CrossRef citations to date
0
Altmetric
Research Article

Epstein–Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1

Joo Hyun KimBiomedical Research Institute
,
Won Seog KimBiomedical Research Institute;Division of Hematology–Oncology, Department of Medicine
&
Chaehwa ParkBiomedical Research Institute;Basic Research Laboratory, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaCorrespondence[email protected] [email protected]
Pages 1586-1591 | Received 24 Nov 2011, Accepted 16 Jan 2012, Published online: 01 Mar 2012

References

  • Weiss LM, Movahed LA, Warnke RA, . Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989;320:502–506.
  • Kwon JM, Park YH, Kang JH, . The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma. Ann Hematol 2006;85:463–468.
  • Fahraeus R, Fu HL, Ernberg I, . Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 1988;42:329–338.
  • Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992;140:769–774.
  • Murray PG, Young LS, Rowe M, . Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease. J Pathol 1992;166:1–5.
  • Peng M, Lundgren E. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Oncogene 1992;7:1775–1782.
  • Gires O, Zimber-Strobl U, Gonnella R, . Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J 1997;16:6131–6140.
  • Huen DS, Henderson SA, Croom-Carter D, . The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 1995;10:549–560.
  • Mcfarland EDC, Izumi KM, Mosialos G. Epstein-Barr virus transformation: involvement of latent membrane protein 1-mediated activation of NFkB. Oncogene 1999;19:6959–6964.
  • Park S, Lee J, Ko YH, . The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 2007;110:972–978.
  • Kim JH, Kim WS, Park C, . Egr-1, a new downstream molecule of Epstein-Barr virus latent membrane protein 1. FEBS Lett 2007;581:623–628.
  • Kim JH, Kim WS, Park C. SNARK, a novel downstream molecule of EBV latent membrane protein 1, is associated with resistance to cancer cell death. Leuk Lymphoma 2008;49:1392–1398.
  • Bonavida B. Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions. Oncogene 2007;26:3629–3636.
  • Stolz C, Hess G, Hähnel PS, . Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis. Blood 2008;112:3312–3321.
  • Suzuki E, Umezawa K, Bonavida B. Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis. Oncogene 2007;26:6184–6193.
  • Jazirehi AR, Vega MI, Bonavida B. Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy. Cancer Res 2007;67:1270–1281.
  • Olejniczak SH, Hernandez-Ilizaliturri FJ, Clements JL, . Acquired resistance to rituxiamb resulting from decreased Bax and Bak expression. Clin Cancer Res 2008;14:1550–1560.
  • Pavan A, Spina M, Canzonieri V, . Recent prognostic factors in duffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies. Leuk Lymphoma 2008;49:2048–2058.
  • Tao YG, Tan YN, Liu YP, . Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner. Cell Signal 2004;16:781–790.
  • Yamanaka Y, Tagawa H, Takahashi N, . Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. Blood 2009;114:3265–3275.
  • Kluiver J, Haralambieva E, de Jong D, . Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 2006;45:147–153.
  • Kluiver J, Poppema S, de Jong D, . BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005;207:243–249.
  • Inomata M, Tagawa H, Guo YM, . MicroRNA-17 - 92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 2007;113:396–402.
  • Linnstaedt SD, Gottwein E, Skalsky RL, . Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol 2010;84:11670–11678.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.